Form 4 for CVS CVS Health
Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-04 · accession 0001127602-22-011678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-06 | 2022-04-04+ | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | S - Sale+OE | $100.12 | -61.3K | 50.1K | -55% | -$6.14M |
| DM | 2022-04-06 | 2022-04-04 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | M - OptEx | $56.79 | +43.3K | 66.3K | +189% | +$2.46M |
| DM | 2022-04-06 | 2022-04-04 | CVS | Finke Daniel P | EVP, Pres, Health Care Benefits | M - OptEx | $0.00 | -43.3K | 27.2K | -61% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | S | D | 27,166 | $100.13 | 50,122.96 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-04 | S | D | 12,032 | $100.13 | 38,090.96 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-04 | M | A | 27,166 | $58.34 | 77,288.96 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-05 | S | D | 5,941 | $100.00 | 32,149.96 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-04 | M | A | 16,161 | $54.19 | 66,283.96 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-04 | S | D | 16,161 | $100.13 | 50,122.96 | D | — | — | |
| 7 | Derivative | Stock Option | 2022-04-04 | M | D | 16,161 | $0.00 | 16,161 | D | $54.19 · 2020-04-01 to 2029-04-01 | 16,161 Common Stock | (F2) Option became exercisable in four equal annual installments, beginning on 4/1/2020. |
| 8 | Derivative | Stock Option | 2022-04-04 | M | D | 27,166 | $0.00 | 27,166 | D | $58.34 · 2021-04-01 to 2030-04-01 | 27,166 Common Stock | (F3) Option became exercisable in four equal annual installments, commencing 4/1/2021. |